Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2016 May 12;6(5):e009254.
doi: 10.1136/bmjopen-2015-009254.

Findings from a pilot Randomised trial of an Asthma Internet Self-management Intervention (RAISIN)

D Morrison  1 , S Wyke  2 , K Saunderson  1 , A McConnachie  3 , K Agur  1 , R Chaudhuri  4 , M Thomas  5 , N C Thomson  4 , L Yardley  6 , F S Mair  1
Affiliations
Clinical Trial

Findings from a pilot Randomised trial of an Asthma Internet Self-management Intervention (RAISIN)

D Morrison et al. BMJ Open. .

Abstract

Objective: To evaluate the feasibility of a phase 3 randomised controlled trial (RCT) of a website (Living Well with Asthma) to support self-management.

Design and setting: Phase 2, parallel group, RCT, participants recruited from 20 general practices across Glasgow, UK. Randomisation through automated voice response, after baseline data collection, to website access for minimum 12 weeks or usual care.

Participants: Adults (age≥16 years) with physician diagnosed, symptomatic asthma (Asthma Control Questionnaire (ACQ) score ≥1). People with unstable asthma or other lung disease were excluded.

Intervention: 'Living Well with Asthma' is a desktop/laptop compatible interactive website designed with input from asthma/ behaviour change specialists, and adults with asthma. It aims to support optimal medication management, promote use of action plans, encourage attendance at asthma reviews and increase physical activity.

Outcome measures: Primary outcomes were recruitment/retention, website use, ACQ and mini-Asthma Quality of Life Questionnaire (AQLQ). Secondary outcomes included patient activation, prescribing, adherence, spirometry, lung inflammation and health service contacts after 12 weeks. Blinding postrandomisation was not possible.

Results: Recruitment target met. 51 participants randomised (25 intervention group). Age range 16-78 years; 75% female; 28% from most deprived quintile. 45/51 (88%; 20 intervention group) followed up. 19 (76% of the intervention group) used the website, for a mean of 18 min (range 0-49). 17 went beyond the 2 'core' modules. Median number of logins was 1 (IQR 1-2, range 0-7). No significant difference in the prespecified primary efficacy measures of ACQ scores (-0.36; 95% CI -0.96 to 0.23; p=0.225), and mini-AQLQ scores (0.38; -0.13 to 0.89; p=0.136). No adverse events.

Conclusions: Recruitment and retention confirmed feasibility; trends to improved outcomes suggest use of Living Well with Asthma may improve self-management in adults with asthma and merits further development followed by investigation in a phase 3 trial.

Trial registration number: ISRCTN78556552; Results.

Keywords: Adherence; Internet; PRIMARY CARE; behaviour change; complex intervention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow of participants through study. *Actual search terms refined iteratively through recruitment (see online supplementary data file for detail). ACQ, Asthma Control Questionnaire score; FeNO, fractional exhaled nitric oxide; NHS, National Health Service.
See this image and copyright information in PMC

References

    1. Masoli M, Fabian D, Holt S et al. . Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469–78. 10.1111/j.1398-9995.2004.00526.x - DOI - PubMed
    1. Normansell R, Walker S, Milan SJ et al. . Omalizumab for asthma in adults and children. Cochrane Database Syst Rev 2014;1:CD003559 10.1002/14651858.CD003559.pub4 - DOI - PMC - PubMed
    1. Torrego A, Solà I, Munoz AM et al. . Bronchial thermoplasty for moderate or severe persistent asthma in adults. Cochrane Database Syst Rev 2014;3:CD009910 10.1002/14651858.CD009910.pub2 - DOI - PMC - PubMed
    1. Powell C, Milan SJ, Dwan K et al. . Mepolizumab versus placebo for asthma. Cochrane Database Syst Rev 2015;7:CD010834 10.1002/14651858.CD010834.pub2 - DOI - PubMed
    1. Ortega HG, Liu MC, Pavord ID et al. . Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 2014;371:1198–207. 10.1056/NEJMoa1403290 - DOI - PubMed

Publication types

MeSH terms